Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Teva
AstraZeneca
Cantor Fitzgerald
Novartis
Fish and Richardson
US Army
Chubb
Fuji
Baxter

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019032

« Back to Dashboard

NDA 019032 describes TENEX, which is a drug marketed by Promius Pharma and is included in one NDA. It is available from one supplier. Additional details are available on the TENEX profile page.

The generic ingredient in TENEX is guanfacine hydrochloride. There are seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.
Summary for 019032
Tradename:TENEX
Applicant:Promius Pharma
Ingredient:guanfacine hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Pharmacology for NDA: 019032
Mechanism of ActionAdrenergic alpha2-Agonists
Medical Subject Heading (MeSH) Categories for 019032
Suppliers and Packaging for NDA: 019032
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TENEX guanfacine hydrochloride TABLET;ORAL 019032 NDA Promius Pharma, LLC 67857-705 67857-705-05 500 TABLET in 1 BOTTLE, PLASTIC (67857-705-05)
TENEX guanfacine hydrochloride TABLET;ORAL 019032 NDA Promius Pharma, LLC 67857-705 67857-705-01 100 TABLET in 1 BOTTLE, PLASTIC (67857-705-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:Oct 27, 1986TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 2MG BASE
Approval Date:Nov 7, 1988TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 3MG BASE
Approval Date:Nov 7, 1988TE:RLD:No

Expired US Patents for NDA 019032

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Promius Pharma TENEX guanfacine hydrochloride TABLET;ORAL 019032-001 Oct 27, 1986 ➤ Subscribe ➤ Subscribe
Promius Pharma TENEX guanfacine hydrochloride TABLET;ORAL 019032-002 Nov 7, 1988 ➤ Subscribe ➤ Subscribe
Promius Pharma TENEX guanfacine hydrochloride TABLET;ORAL 019032-003 Nov 7, 1988 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
Teva
Fish and Richardson
Baxter
Argus Health
UBS
Chinese Patent Office
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot